Trial intelligence / Profile preview

FAVOR: Fimasartan vs. Valsartan vs. Atenolol in Ischemic Stroke

NCT02403349Phase 4Unknown

Sponsor
Ajou University School of Medicine
Start
May 2012
Primary completion
May 2015
Modality
Small Molecules
01

Overview

Phase 4, randomised, double-blind trial of fimasartan in hypertension (HTN), sponsored by Ajou University School of Medicine. Status: unknown.

02

Drugs

fimasartan
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT02403349.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02403349.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call